Patient Assistance Programs
 
Fighting AIDS in Africa
 
Bristol-Myers Squibb Foundation & Corporate Philanthropy
 
Product Integrity
 
Sustainability: Our Plan for Responsible Growth
 
Environment, Health & Safety Policy
 
Medical Education Grants And Charitable Contributions
 
Clinical Outcomes And Research Grants
 
Position On Key Issues

 

  » BMS.com Home » Corporate Responsibility » Requests For Proposals - Immunoscience
SEARCH INDEX

Immunoscience RFPs

BMS is requesting proposals for Independent Medical Education programs in the following disease areas in the United States:

Rheumatoid Arthritis

Proposals should address the educational needs of the following healthcare providers:

  • Rheumatologists
  • Rheumatology Nurses
  • Nurse Practitioners
  • Physician Assistants

If your proposal addresses educational needs of Rheumatologists or other healthcare providers outside of the U.S., please include suggestions for extending the program in your proposal.

Although proposals including any method of education will be considered, the following educational modalities are of particular interest:

Internet Based Education
Enduring Materials (e.g. CD-ROM, Journal Supplements)
Satellite Broadcasts
Teleconferences

All responses must be received no later than eight weeks prior to the start date of this proposed program. In addition, responses must be received by the first Wednesday of the month in order to be eligible for review during that month.


Bristol-Myers Squibb is requesting proposals for Independent Medical Education programs in the following disease areas:

Transplant Therapeutics

Proposals should address the educational needs of the following healthcare providers:

  • Transplant Physicians & Surgeons
  • Nephrologists
  • Transplant Nurses & Coordinators
  • Physician Assistants
  • Pharmacists

If your proposal addresses educational needs of similar physicians or healthcare providers outside of the U.S., please include suggestions for extending the program in your proposal.

Although proposals including any method of education will be considered, the following educational modalities are of particular interest:

Internet Based Education
Enduring Materials (e.g. CD-ROM, Journal Supplements)
Satellite Broadcasts
Teleconferences

All responses must be received no later than eight weeks prior to the start date of this proposed program. In addition, responses must be received by the first Wednesday of the month in order to be eligible for review during that month.

 

Click here to continue >>

 




[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy. CRISP#: ZN-I0241 12/2006

 

Our Medical Grants and Charitable Contributions program supports educational initiatives.
SEARCH INDEX